US FDA issues two observations after inspection of Lupin’s Pithampur unit Press Trust of India Feb 12, 2020 The inspection was carried out between February 3 and February 11, 2020 Lupin said the US health regulator has issued two…
Lupin gets warning letter from US FDA for Mandideep facility Press Trust of India Sep 19, 2019 Lupin said there are no drug master file and abbreviated new drug applications (ANDA) pending review or approval from the…
US FDA raises concerns over Lupin’s plant at Pithampur Usha Sharma Feb 24, 2015 FDA inspected the plant in January this year and listed six observations on the manufacturing processes at the plant
